Greg Leonberger, FSA, EA, MAAA, FCA
Partner, Director of Research
Last week was a painful one for the equity markets as fears about the coronavirus drove investors out of stocks and markets into correction territory. The following newsletter summarizes last week’s developments and provides specific commentary on what to watch for across the major asset classes that constitute investor portfolios.
Read > March 2: Coronavirus Update and Portfolio Guidance
As always, please reach out to your consultant or our research team for more details about any of the information presented in this update. For more Marquette coverage on coronavirus, reference our previous newsletter (January 28) and Chart of the Week posts (February 13, February 21, February 26).
The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.
01.12.2026
The capture of Venezuelan president Nicolás Maduro is a watershed moment for a country whose natural resource economy has been…
01.07.2026
Please join Marquette’s research team for our 2026 Market Preview Webinar analyzing 2025 across the economy and various asset classes…
01.05.2026
The development of artificial intelligence is advancing along two largely distinct paths. The first centers on generative AI powered by…
12.29.2025
While the holiday season was once marked by bustling bars, readers may notice that nightlife isn’t what it used to…
12.22.2025
Private equity is known for being an illiquid asset class, with investments typically locked up for several years and limited…
12.15.2025
While technology-oriented firms have made their presence known in equity markets for several years, these companies have made waves in…
Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.
We respect your privacy. We will never share or sell your information.
If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.
Contact Us >